Shanshan Xu

Company: Bambusa Therapeutics

Job title: Chief Executive Officer

Bio:

Shanshan Xu, MD, PhD, is the Founder and CEO of Bambusa Therapeutics, a rapidly growing clinical-stage biotechnology company specializing in developing transformative inflammatory and immunological (I&I) therapeutics. Bambusa was founded with a belief that the I&I field is long overdue for innovative approaches and transformative cutting-edge solutions. 
Prior to founding Bambusa, Shanshan served as the head of Global External Innovations at BioNTech, where she and her team identified best-in-class assets and technologies. Shanshan also spent time on Wall Street as a Research Analyst and holds a Ph.D. from UC-Irvine and an MBA from MIT. 

Seminars:

Evaluating Bi-Specific Antibody & Cell Engager Targets, Safety & Efficacy to Uncover Their Commercial Potential 12:10 pm

Exploring emerging classes of cell engager and bispecific therapies, evaluating target populations, including macrophages, to identify applications in wider autoimmune diseases Comparing toxicity concerns for a broad population or efficacy in more targeted populations to evaluate the safety of engager and antibody applications Evaluating the safety and efficacy of bispecific antibody & cell engagers, in…Read more

day: Day Two